Nonalcoholic Fatty Liver Disease: References

1. Patrick L. Nonalcoholic fatty liver disease: relationship to insulin sensitivity and oxidative stress. Treatment approaches using vitamin E, magnesium, and betaine. Altern Med Rev. 2002;7:276–291.

2. Cortez–Pinto H, Camilo ME. Non–alcoholic fatty liver disease/non–alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course. Best Pract Res Clin Gastroenterol. 2004;18:1089–1104

3. Sass DA, Chang P, Chopra KB. Nonalcoholic fatty liver disease: a clinical review. Dig Dis Sci. 2005;50:171–180.

4. Barnard ND, Scialli AR, Turner–McGrievy G, Lanou AJ, Glass J. The effects of a low–fat, plant–based dietary intervention on body weight, metabolism, and insulin sensitivity. Am J Med. 2005;118:991–997.

5. Mach T. Fatty liver––current look at the old disease. Med Sci Monit. 2000;6:209–216.

6. Kuo CS, Lai NS, Ho LT, Lin CL. Insulin sensitivity in Chinese ovo–lactovegetarians compared with omnivores. Eur J Clin Nutr. 2004;58:312–316.

7. Szeto YT, Kwok TC, Benzie IF. Effects of a long–term vegetarian diet on biomarkers of antioxidant status and cardiovascular disease risk. Nutrition. 2004;20:863–866.

8. Gawrieh S, Opara EC, Koch TR. Oxidative stress in nonalcoholic fatty liver disease: pathogenesis and antioxidant therapies. J Investig Med. 2004;52:506–514.

9. Hua NW, Stoohs RA, Facchini FS. Low iron status and enhanced insulin sensitivity in lacto–ovo vegetarians. Br J Nutr. 2001;86:515–519.

10. Friis–Liby I, Aldenborg F, Jerlstad P, Rundstrom K, Bjornsson E. High prevalence of metabolic complications in patients with non–alcoholic fatty liver disease. Scand J Gastroenterol. 2004;39:864–869.

11. Kondili LA, Tosti ME, Szklo M, et al. The relationships of chronic hepatitis and cirrhosis to alcohol intake, hepatitis B and C, and delta virus infection: a case–control study in Albania. Epidemiol Infect. 1998;121:391–395.

12. Pares A, Tresserras R, Nunez I, et al. Prevalence and factors associated to the presence of fatty liver in apparently healthy adult men. Med Clin (Barc). 2000;11:561–565.

13. Paquot N, Delwaide J. Fatty liver in the intensive care unit. Curr Opin Clin Nutr Metab Care. 2005;8:183–187.

14. Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest. 2004;114:147–152.